ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,410,000 | +62.7% | 72,110 | +18.6% | 0.01% | +75.0% |
| Q2 2021 | $7,628,000 | -9.6% | 60,784 | -2.3% | 0.00% | -20.0% |
| Q1 2021 | $8,434,000 | +23.3% | 62,194 | +16.3% | 0.01% | +25.0% |
| Q4 2020 | $6,842,000 | +26.1% | 53,479 | +10.9% | 0.00% | 0.0% |
| Q3 2020 | $5,426,000 | +15.3% | 48,222 | -2.3% | 0.00% | 0.0% |
| Q2 2020 | $4,705,000 | +6.9% | 49,382 | +0.8% | 0.00% | 0.0% |
| Q1 2020 | $4,402,000 | +110.2% | 48,987 | +24.1% | 0.00% | +100.0% |
| Q4 2019 | $2,094,000 | +40.4% | 39,487 | +4.7% | 0.00% | +100.0% |
| Q3 2019 | $1,491,000 | +32.8% | 37,731 | +38.0% | 0.00% | 0.0% |
| Q2 2019 | $1,123,000 | +0.5% | 27,346 | +14.0% | 0.00% | 0.0% |
| Q1 2019 | $1,117,000 | -50.7% | 23,994 | -53.9% | 0.00% | -50.0% |
| Q4 2018 | $2,266,000 | -22.7% | 52,023 | +1.5% | 0.00% | -33.3% |
| Q3 2018 | $2,933,000 | +1137.6% | 51,245 | +948.0% | 0.00% | – |
| Q2 2018 | $237,000 | -77.1% | 4,890 | -82.3% | 0.00% | -100.0% |
| Q3 2017 | $1,033,000 | +259.9% | 27,672 | +192.6% | 0.00% | – |
| Q2 2017 | $287,000 | +19.1% | 9,456 | +3.9% | 0.00% | – |
| Q1 2017 | $241,000 | -20.7% | 9,101 | +8.3% | 0.00% | – |
| Q3 2016 | $304,000 | +1.7% | 8,401 | -4.5% | 0.00% | – |
| Q2 2016 | $299,000 | +30.0% | 8,797 | +1.0% | 0.00% | – |
| Q1 2016 | $230,000 | -36.6% | 8,707 | +17.0% | 0.00% | -100.0% |
| Q4 2015 | $363,000 | – | 7,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |